Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V V Likhvantsev

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Anesteziologiia I Reanimatologiia|July 1, 1993
[Comparative aspects of the use of dalargin in comprehensive anesthesiologic protection during the surgical correction of congenital heart disease]V V Likhvantsev, V I Smirnova, A Iu Kuznetsov, et al.
Anesteziologiia I Reanimatologiia|July 1, 1996
[Monitoring of the informative saturation of EEG: a new method for intraoperative assessment of antinociceptive defense of the organism]O V Petrov, V V Likhvantsev, V I Smirnova, et al.
Anesteziologiia I Reanimatologiia|December 16, 2003
[Effect of early enteral feeding on immune status in the immediate postoperative period]V V Kazennov, M N Shishkin, D B Amerov, et al.
Anesteziologiia I Reanimatologiia|July 1, 1989
[Dalargin--a basic means of intraoperative protection of a patient during correction of an atrial septal defect under conditions of artificial circulation: a new method of anesthesia]B M Shloznikov, V V Likhvantsev, A Iu Kuznetsov, et al.
Toxicology Letters|May 9, 2013
Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicityE Y Plotnikov, O A Grebenchikov, V A Babenko, et al.
Anesteziologiia I Reanimatologiia|October 14, 2014
[Molecular mechanisms of ischemic-reperfusion syndrome and its personalized therapy]O A Grebenchikov, V V Likhvantsev, E Iu Plotnikov, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|March 1, 1990
[The antinociceptive properties of dalargin as an agent of anesthesiologic protection]B M Shloznikov, S G Donich, O A Grebenchikova, et al.
Khirurgiia|July 1, 1990
[Use of dalargin in complex anesthesiological protection during operations on the abdominal organs]V V Likhvantsev, B M Shloznikov, V I Smirnova, et al.
Anesteziologiia I Reanimatologiia|July 8, 2015
[PERIOPERATIVE CARE FOR PATIENTS WITH UNDERLYING ARTERIAL HYPERTENSION (CLINICAL GUIDELINES)], I B Zabolotskikh, K M Lebedinskii, et al.
Anesteziologiia I Reanimatologiia|June 13, 2018
PREVENTION OF HEART FAILURE PATIENTS WITH DECREASED EJECTION FRACTION IN NON-CARDIAC SURGERY: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION?V V Likhvantsev, D N Marchenko, O A Grebenshchikov, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Anesteziologiia I Reanimatologiia|July 1, 1993
[Comparative aspects of the use of dalargin in comprehensive anesthesiologic protection during the surgical correction of congenital heart disease]V V Likhvantsev, V I Smirnova, A Iu Kuznetsov, et al.
Anesteziologiia I Reanimatologiia|July 1, 1996
[Monitoring of the informative saturation of EEG: a new method for intraoperative assessment of antinociceptive defense of the organism]O V Petrov, V V Likhvantsev, V I Smirnova, et al.
Anesteziologiia I Reanimatologiia|December 16, 2003
[Effect of early enteral feeding on immune status in the immediate postoperative period]V V Kazennov, M N Shishkin, D B Amerov, et al.
Anesteziologiia I Reanimatologiia|July 1, 1989
[Dalargin--a basic means of intraoperative protection of a patient during correction of an atrial septal defect under conditions of artificial circulation: a new method of anesthesia]B M Shloznikov, V V Likhvantsev, A Iu Kuznetsov, et al.
Toxicology Letters|May 9, 2013
Nephroprotective effect of GSK-3β inhibition by lithium ions and δ-opioid receptor agonist dalargin on gentamicin-induced nephrotoxicityE Y Plotnikov, O A Grebenchikov, V A Babenko, et al.
Anesteziologiia I Reanimatologiia|October 14, 2014
[Molecular mechanisms of ischemic-reperfusion syndrome and its personalized therapy]O A Grebenchikov, V V Likhvantsev, E Iu Plotnikov, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|March 1, 1990
[The antinociceptive properties of dalargin as an agent of anesthesiologic protection]B M Shloznikov, S G Donich, O A Grebenchikova, et al.
Khirurgiia|July 1, 1990
[Use of dalargin in complex anesthesiological protection during operations on the abdominal organs]V V Likhvantsev, B M Shloznikov, V I Smirnova, et al.
Anesteziologiia I Reanimatologiia|July 8, 2015
[PERIOPERATIVE CARE FOR PATIENTS WITH UNDERLYING ARTERIAL HYPERTENSION (CLINICAL GUIDELINES)], I B Zabolotskikh, K M Lebedinskii, et al.
Anesteziologiia I Reanimatologiia|June 13, 2018
PREVENTION OF HEART FAILURE PATIENTS WITH DECREASED EJECTION FRACTION IN NON-CARDIAC SURGERY: LEVOSIMENDAN OR ANESTHETIC CARDIOPROTECTION?V V Likhvantsev, D N Marchenko, O A Grebenshchikov, et al.
Pageof 6